AstraZeneca Pharma India Limited — Others, 10-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

AstraZeneca Pharma India Limited has announced a board meeting to address compliance with Regulation 74(5) of SEBI regulations, confirmed by a certificate from their Registrar and Transfer Agents. This compliance underlines the company’s commitment to maintaining good governance practices. For investors, this development could signal a proactive approach to regulatory adherence, which may inspire a positive outlook on the company's operational integrity and foster confidence in its management.